![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » EUROSCREEN RECEIVES KEY PATENT FOR PURINERGIC RECEPTOR
EUROSCREEN RECEIVES KEY PATENT FOR PURINERGIC RECEPTOR
May 26, 2006
Euroscreen SA May 26 announced that it was awarded a US patent that covers the use of a G-protein-coupled receptor (GPCR) known as the human P2Y11 receptor. Euroscreen's patent protects the sequence of P2Y11 receptor and research tools comprising this sequence.
PR Web (http://www.prweb.com/releases/2006/5/prweb384934.htm)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct